Search results for "Advanced"

showing 10 items of 750 documents

Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication.

2011

Objective To demonstrate that the use of donor sperm leads to varying outcome rates and that its use has evolved. Design Retrospective observational cohort study. Setting University-affiliated private IVF setting. Patient(s) Women (2,934) undergoing donor insemination (DI) or IVF with donor sperm (IVF-D). Intervention(s) None. Main Outcome Measurement(s) We evaluated the distribution of the clinical indications for the use of donated sperm, studying the reproductive outcome. Result(s) A total of 1,663 DI (57%) and 1,271 IVF-D (43%) were performed. There were significant differences in the indications for the use of donated sperm (DI vs. IVF-D). Regarding pregnancy rates (PR), cases of nonob…

AdultMalemedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentPopulationFertilization in VitroBiologyRisk AssessmentIntracytoplasmic sperm injectionPregnancyRisk FactorsmedicineOdds RatioHumansAdvanced maternal ageSperm Injections Intracytoplasmiceducationreproductive and urinary physiologyAzoospermiaRetrospective StudiesGynecologyPregnancyeducation.field_of_studyIn vitro fertilisationChi-Square Distributionurogenital systemObstetricsObstetrics and GynecologySingle Personmedicine.diseaseSpermSpermatozoaTissue DonorsLogistic ModelsTreatment OutcomeReproductive MedicineSpainInsemination Artificial HeterologousFemaleDonor spermCohort studyMaternal AgeFertility and sterility
researchProduct

Temporal Trends in Sex Differences With Regard to Stroke Incidence

2016

Background and Purpose— We evaluated temporal trends in stroke incidence between men and women to determine whether changes in the distribution of vascular risk factors have influenced sex differences in stroke epidemiology. Methods— Patients with first-ever stroke including ischemic stroke, spontaneous intracerebral hemorrhage, subarachnoid hemorrhage, and undetermined stroke between 1987 and 2012 were identified through the population-based registry of Dijon, France. Incidence rates were calculated for age groups, sex, and stroke subtypes. Sex differences and temporal trends (according to 5-year time periods) were evaluated by calculating incidence rate ratios (IRRs) with Poisson regress…

AdultMalemedicine.medical_specialtyStroke registry030204 cardiovascular system & hematologyVascular riskBrain Ischemia03 medical and health sciencesSex Factors0302 clinical medicineSex factorsEpidemiologymedicineHumansRegistriesStrokeAgedCerebral HemorrhageAged 80 and overAdvanced and Specialized Nursingbusiness.industryIncidenceIncidence (epidemiology)Middle AgedSubarachnoid Hemorrhagemedicine.diseaseStrokePhysical therapyFemaleFranceNeurology (clinical)Cardiology and Cardiovascular MedicineStroke incidencebusiness030217 neurology & neurosurgeryDemographyStroke
researchProduct

Determinants of Case Fatality After Hospitalization for Stroke in France 2010 to 2015.

2019

Background and Purpose— The aims of this study were to (1) describe early and late case fatality rates after stroke in France, (2) evaluate whether their determinants differed, and (3) analyze time trends between 2010 and 2015. Methods— Data were extracted from the Système National des données de santé database. Patients hospitalized for stroke each year from 2010 to 2015, aged ≥18 years, and affiliated to the general insurance scheme were selected. Cox regressions were used to separately analyze determinants of 30-day and 31- to 365-day case fatality rates for each stroke type (ischemic, intracerebral hemorrhage, and subarachnoid hemorrhage). Results— In 2015, of the 73 124 persons hospit…

AdultMalemedicine.medical_specialtySubarachnoid hemorrhageAdolescentDatabases FactualComorbidity030204 cardiovascular system & hematologyCcomorbidityBrain Ischemia03 medical and health sciencesYoung Adult0302 clinical medicineAge DistributionCase fatality ratemedicineHumansHospital MortalityMortalitySex DistributionStrokeAntihypertensive AgentsAgedCerebral HemorrhageAdvanced and Specialized NursingAged 80 and overbusiness.industryMiddle AgedSubarachnoid Hemorrhagemedicine.diseasePrognosisComorbidity3. Good healthStrokeHospitalizationEmergency medicineHypertension[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFemaleNeurology (clinical)FranceCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgeryStroke
researchProduct

Nursing Workload, Knowledge about Pain, and Their Relation to Pain Records

2020

To study the relationship between frequency of pain assessment and nursing workload, and also to analyze the frequency of pain assessment and its relation to knowledge and attitudes toward pain on nursing professionals in intensive care unit.An ambispective study was conducted in a Spanish tertiary-level intensive care unit between October 2017 and April 2018. For measurement of workload, the Nursing Activities Score scale was used, and for measurement of pain knowledge, the Knowledge and Attitudes Survey Regarding Pain was used.There were 1,207 measurements among 41 nurses and 1,838 among 317 patients. The average nursing workload was high (70.97 points). We found statistically significant…

AdultMalemedicine.medical_specialtyeducationMEDLINENursing workloadDocumentationWorkloadlaw.invention03 medical and health sciences0302 clinical medicinelawPain assessmentHumansMedicine030212 general & internal medicinePain.knowledgePain MeasurementAdvanced and Specialized Nursing030504 nursingbusiness.industryWorkloadMiddle AgedIntensive care unitIntensive Care UnitsScale (social sciences)Physical therapyFemaleNursing CareClinical Competence0305 other medical sciencebusinessPain Management Nursing
researchProduct

Personalized Goal for Dyspnea and Clinical Response in Advanced Cancer Patients

2018

Abstract Background The clinical response after comprehensive symptom management is difficult to determine in terms of a clinically important difference. Moreover, therapies should try to reach the threshold perceived by the individual patient for the determination of a favorable response to a treatment. Measures The Edmonton Symptom Assessment Score (ESAS) was measured at admission (T0), and seven days after starting palliative care (T7). Patient Global Impression and Goal Response after one week of palliative care and its relation with the Personalized Dyspnea Goal were measured at T7. Intervention Patients admitted to palliative care units underwent a comprehensive symptom assessment by …

AdultMalemedicine.medical_specialtypersonalized symptom goalPalliative careDecision MakingSymptom assessmentSeverity of Illness Index03 medical and health sciences0302 clinical medicineNeoplasmsAdvanced cancerHumansMedicine030212 general & internal medicinePrecision MedicineGeneral NursingSpecialist palliative careglobal impression of changeNursing (all)2901 Nursing (miscellaneous)AgedAged 80 and oversymptom assessmentpalliative carebusiness.industrySymptom managementMinimal clinically important differenceDisease ManagementMiddle AgeddyspneaAnticipation PsychologicalAdvanced cancerrespiratory tract diseasesIntensity (physics)Treatment OutcomeAnesthesiology and Pain Medicine030220 oncology & carcinogenesisPhysical therapyDeliriumFemaleNeurology (clinical)medicine.symptombusiness
researchProduct

Systemic Treatment in Advanced Phyllodes Tumor of the Breast: A Multi-institutional European Retrospective Case-series Analyses

2022

Abstract Background: We aimed at investigating outcome of systemic treatments in advanced breast PT. Methods: All cases of advanced breast PT treated with systemic treatments from 1999 to 2019, in one of the referral sarcoma centres involved in the study, were retrospectively reviewed. Results: 56 female patients were identified. Median age was 52 (range 25-76) years. Patients re-ceived a median number of 2 systemic treatments (range 1-4). Best responses according to RECIST were: 1 (3.7%) CR, 11 (40.7%) PR, 6 (22.2%) SD, 9 (33.3%) PD with anthracyclines plus ifosfamide (AI); 2 (16.7%) PR, 4 (33.3%) SD, 6 (50.0%) PD with anthracycline alone; 3 (18.8%) PR, 4 (25.0%) SD, 9 (56.3%) PD with high…

AdultOncologyCancer Researchmedicine.medical_specialtyAdvanced setting; Breast tumor; Chemotherapy; Phyllodes; SarcomaBreast tumorBreast NeoplasmsAdvanced settingInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansMedicineChemotherapyResponse Evaluation Criteria in Solid TumorsAgedRetrospective StudiesSeries (stratigraphy)business.industryPhyllodes tumorPhyllodesSarcomaMiddle Agedmedicine.diseaseOncologyFemalebusiness
researchProduct

Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study

2021

Background: The aim of the present study was to assess the prognostic value of tumour-free distance (TFD), defined as the minimum distance of uninvolved stroma between the tumour and peri-cervical stromal ring, in early-stage cervical cancer. Methods: Patients with pathologic FIGO 2009 stage IA1–IIA2 cervical cancer, treated by primary radical surgical treatment between 01/2000 and 11/2019, were retrospectively included. Adjuvant treatment was administered according to the presence of previously established pathologic risk factors. TFD was measured histologically on the hysterectomy specimen. Pre-operative TFD measured at MRI-scan from a cohort of patients was reviewed and compared with pat…

AdultOncologyCancer Researchmedicine.medical_specialtyMultivariate analysismedicine.medical_treatmentUterine Cervical NeoplasmsHysterectomyArticlesurgery03 medical and health sciences0302 clinical medicineSurgical oncologyInternal medicinelocally advanced cervical cancerHumansMedicineStage (cooking)AgedNeoplasm StagingRetrospective StudiesAged 80 and overCervical cancer...Hysterectomybusiness.industrylocally advanced cervical cancer surgeryMiddle AgedPrognosismedicine.diseaseMagnetic Resonance ImagingSurvival AnalysisSettore MED/40 - GINECOLOGIA E OSTETRICIATreatment OutcomeOncologyLymphatic Metastasis Magnetic Resonance ImagingLymphatic Metastasis030220 oncology & carcinogenesisCohortRadiographic Image Interpretation Computer-AssistedFemaleLymphbusinessCohort studyBritish Journal of Cancer
researchProduct

European Resuscitation Council Guidelines 2021: Adult advanced life support.

2021

These European Resuscitation Council Advanced Life Support guidelines, are based on the 2020 International Consensus on Cardiopulmonary Resuscitation Science with Treatment Recommendations. This section provides guidelines on the prevention of and ALS treatments for both in-hospital cardiac arrest and out-of-hospital cardiac arrest.

AdultResuscitationConsensusCardiac arrest; resuscitation; comamedicine.medical_treatment[SDV]Life Sciences [q-bio]ResuscitationeducationMEDLINE030204 cardiovascular system & hematologyEmergency Nursing03 medical and health sciences0302 clinical medicineSettore MED/41 - ANESTESIOLOGIAmedicineHumansCardiopulmonary resuscitationComaComputingMilieux_MISCELLANEOUSbusiness.industry030208 emergency & critical care medicinemedicine.diseaseCardiac arrestPrognosisCardiopulmonary Resuscitation3. Good healthAdvanced life supportEmergency MedicineMedical emergencyCardiology and Cardiovascular MedicinebusinessOut-of-Hospital Cardiac ArrestResuscitation
researchProduct

European Resuscitation Council Guidelines 2021: Executive summary

2021

Abstract: Informed by a series of systematic reviews, scoping reviews and evidence updates from the International Liaison Committee on Resuscitation, the 2021 European Resuscitation Council Guidelines present the most up to date evidence-based guidelines for the practice of resuscitation across Europe. The guidelines cover the epidemiology of cardiac arrest; the role that systems play in saving lives, adult basic life support, adult advanced life support, resuscitation in special circumstances, post resuscitation care, first aid, neonatal life support, paediatric life support, ethics and education.

AdultResuscitationResuscitationmedicine.medical_treatmenteducation030204 cardiovascular system & hematologyEmergency Nursing03 medical and health sciences0302 clinical medicineresuscitation ; guidelines ; summaryNursingFirst AidHumansMedicineCardiopulmonary resuscitation610 Medicine & healthChildExecutive summarybusiness.industryInfant NewbornBasic life support030208 emergency & critical care medicineCardiopulmonary ResuscitationHeart ArrestAdvanced life supportEuropeSystematic reviewLife supportEmergency MedicineHuman medicineCardiology and Cardiovascular MedicinebusinessSystematic Reviews as TopicFirst aidResuscitation
researchProduct

Successful treatment of a young patient with locally advanced clear cell adenocarcinoma of the uterine cervix undergoing chemoradiation followed by r…

2014

Clear cell adenocarcinoma (CCAC) of the uterine cervix is a rare variant of cervical adenocarcinoma accounting for approximately 4-9% of this disease. Given the rarity of this pathological entity, the optimal treatment management is far from being defined. Earlier evidence suggested that the prognosis of patients bearing cervical CCAC is worse than with other histotypes, thus making the investigation of multimodal treatment strategies clinically worthwhile. Herein, we report the first case of locally advanced, large size cervical CCAC in a young woman who was triaged to concomitant chemoradiotherapy followed by radical surgery and experienced a pathologically assessed optimal response to th…

Adultmedicine.medical_specialtyAdvanced clear cell adenocarcinomaUterine Cervical NeoplasmRadical surgeryUterine Cervical NeoplasmsDisease-Free SurvivalObstetrics and gynaecologyadenocarcinoma uterine cervixUterine cervixmedicineHumansCombined Modality TherapyClear-cell adenocarcinomaRadical surgeryPathologicalSettore MED/08 - ANATOMIA PATOLOGICAbusiness.industryObstetrics and GynecologyMultimodal therapyChemoradiotherapy Adjuvantmedicine.diseaseMultimodal approachCombined Modality TherapyImmunohistochemistryMagnetic Resonance ImagingSurgeryChemoradiationReproductive MedicineAdenocarcinomaFemalebusinessChemoradiotherapyAdenocarcinoma Clear CellHuman
researchProduct